LAVAL – Moderna has completed construction of its state-of-the art mRNA manufacturing facility in Laval, Quebec. The facility is expected to be ready to manufacture respiratory mRNA vaccines for Canadians in 2025, pending regulatory approvals and certifications, ensuring all vaccines manufactured meet the strictest quality, safety and performance standards. The construction of this facility marks an important milestone in Moderna’s …
Ottawa – The Infectious Disease and Climate Change (IDCC) Program addresses the rise of infectious diseases and their health impacts as a result of our changing climate. This program supports the Government of Canada to deliver on its commitments in the Pan-Canadian Framework on Clean Growth and Climate Change and the Government of Canada’s Adaptation Action Plan, as part of the National …
Ottawa – The impact of climate change is widespread – it affects our environment, our communities, and our health. It also means an increase in climate-sensitive infectious diseases. The World Health Organization (WHO) has identified climate change as one of the biggest threats to global health. Over the past ten years, we have seen the emergence and re-emergence of infectious …
Ottawa – Personal protective measures are actions you can take to reduce your risk of getting or spreading respiratory infectious diseases, such as: the flu COVID-19 respiratory syncytial virus (RSV) These actions are also known as public health measures that can be used by individuals. Personal protective measures work by breaking the chain of infection. This means stopping viruses and …
Washington – A new study reported by USA Today, says that the mRNA vaccine technology, originally focusing on cancer treatments, can now be used for infectious diseases. The study was presented recently at a research conference that highlighted “after nearly two years, patients who received mRNA vaccine jabs created by Moderna and Merck 44% avoided new tumours and were more …
